Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

24.56
-0.1349-0.55%
Post-market: 24.55-0.0094-0.04%16:10 EDT
Volume:2K
Turnover:51.59K
Market Cap:5.65M
PE:- -
High:24.72
Open:24.72
Low:24.47
Close:24.69
52wk High:27.94
52wk Low:22.89
Shares:230.00K
Float Shares:230.00K
Volume Ratio:7.12
T/O Rate:0.91%
Dividend:0.41
Dividend Rate:1.68%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

JPMorgan Adjusts Price Target on Eli Lilly to $1,500 From $1,400, Maintains Overweight Rating

MT Newswires Live
·
Sep 28

Eli Lilly's Olumiant Gets FDA Approval for Severe Alopecia Areata in Adolescents

MT Newswires Live
·
Sep 28

Nektar selloff on trial brings ‘strong entry point,’ says BTIG

TIPRANKS
·
Sep 28

ETF Weekly | QCML Soars 27%; INTW, AMUU, FBL, AMDL Jump 26%; SOXL Rallies 22%; Semiconductor Longs Lead

ETF Weekly
·
Sep 27

Viking Therapeutics Rallies as Obesity Drug Hopes Rise

TIPRANKS
·
Sep 26

Novo Nordisk (0QIU) Receives a Hold from Bank of America Securities

TIPRANKS
·
Sep 26

Eli Lilly Gets Expanded Label Approval from FDA for Alopecia Drug

Dow Jones
·
Sep 26

FDA Approves Lilly's Olumiant (Baricitinib) for Pediatric Patients 12 Years of Age and Older with Severe Alopecia Areata

THOMSON REUTERS
·
Sep 26

Scholar Rock Poised for De-risked Commercial Ramp in Neuromuscular Space, Wedbush Says

MT Newswires Live
·
Sep 26

Top Midday Stories: Akamai's $11.6 Billion Anthropic Deal; Scholastic Q1 Loss Widens; Nektar Awarded $90 Million in Eli Lilly Case

MT Newswires Live
·
Sep 26

Sector Update: Healthcare Stocks Edge Higher Premarket Friday

MT Newswires Live
·
Sep 25

Scholar Rock added to Best Ideas List at Wedbush

TIPRANKS
·
Sep 25

Novo Bets on Next Chapter While Eli Lilly Extends Its GLP-1 Dominance

Deep News
·
Sep 25

Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing

THOMSON REUTERS
·
Sep 25

After Capital-Markets Day Flop, Novo Strikes Licensing Deal That Sends a Swedish Company's Stock Soaring

Dow Jones
·
Sep 25

Novo Nordisk Licenses Nanexa Drug Delivery Technology

MT Newswires Live
·
Sep 25

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.96%

TIPRANKS
·
Sep 25

Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race

TIPRANKS
·
Sep 25

Scholar Rock Holding is Maintained at Buy by Truist Securities

Dow Jones
·
Sep 25

Novo Nordisk A/S Series B Stock Rises Thursday, Outperforms Market

Dow Jones
·
Sep 25